Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

June UNC Health System Pharmacy Resident CE Series


Due to concerns about the novel coronavirus, and consistent with ongoing efforts to reduce spread of the virus, attendance for these CE sessions will be WEBINAR ONLY.  Please see instructions below for registration.
 
PLEASE FOLLOW THE STEP-BY-STEP INSTRUCTIONS BELOW – DO NOT SKIP STEPS!
 
STEP 1:  SIGN INTO YOUR ACCOUNT AND REGISTER FOR EACH SESSION YOU WOULD LIKE TO ATTEND
** If you do not register for the CE at this link, you will not be able to access the evaluations to earn credit
** EVERYONE must register BEFORE the session date. NO NEW REGISTRATIONS WILL BE ADDED AFTER THE PROGRAM DATE
** You will receive an email confirming your registration at the email address provided – if you do not receive a confirmation email, try to register again
**New sessions may be added throughout the month, so do not assume you are automatically registered for all sessions.
 
STEP 2:  AFTER SUCCESSFULLY REGISTERING ON THIS SITE - AT THE TIME OF THE PROGRAM, EXPAND THE MODULE AT THE BOTTOM OF THIS PAGE AND CLICK THE WEBEX LINK.
The Link will not be emailed to you. It can only be found on this page.
** submit your contact information
 
STEP 3:  Collect the presenter code for each of the CEs that you attend
** EVERYONE will need the presenter codes to access evaluations and earn CE credit
 
STEP 4:  You will receive an automated email to log in and complete evaluations
** Evaluations must be completed within 60 days of the CE session
** You will need the presenter codes to access each evaluation
** Evaluations MUST be completed within 60 days of the program date to earn CE credit!

Date: Jun 1, 2021 05:00 PM - Jun 30, 2021 06:00 PM

CE Hours

3.00

CE Units

0.300

Registration closes on Jun 30, 2021 05:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
 
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.

 

If paying by check please mail to the address below:

UNC Eshelman School of Pharmacy
Attn: Continuing Education
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
 
 
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**

Co-Sponsor(s)

UNC Health System

Support/Credits

 
 
 
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
 
 
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
 
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series.
  1. UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
  2. Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded

 

 

 

   

The aim is to discuss the benefit, challenges and landscape of implementing pharmacogenomics into practice. Guidelines will be discussed and the discrepancies between guidelines.  Barriers will be identified   and strategies to enhance utilization will be discussed to help better care for our patients.
 

Objectives

  • Discuss the evidence for using pharmacogenomics to optimize medication use
  • Identify barriers to the implementation of Pharmacogenomics (PGx)
  • Purpose implementation strategies that will enhance utilization and integration of PGx in routine clinical practice

Speaker(s)/Author(s)

Austin Gardner, PharmD
PGY1/MS Health-System Pharmacy Administration and Leadership


Brief Bio : Austin is a PGY1/MS Health-System Pharmacy Administration and Leadership resident. He is from Knoxville, TN and completed his pharmacy school at East Tennessee State University in Johnson City, TN. He has a passion for advancing healthcare through advocacy, automation and policy.

Activity Number

0046-9999-21-173-L04-P
Date: 06/03/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
   

 

   

In recent years there have been updates to sickle cell therapy. This CE presentation aims to update pharmacists on current therapies, as well as medications that are coming down the pipeline.
 

Objectives

  • Compare disease-modifying treatments for sickle cell disease
  • Outline an optimal treatment for a patient with sickle cell disease
  • Explain barriers to treatment for patients with sickle cell disease

Speaker(s)/Author(s)

Greg Norsten, PharmD
Pharmacy Resident

Activity Number

0046-9999-21-176-L01-P
Date: 06/10/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Location

Online
   

 

   

Post Transplant Diabetes Mellitus (PTDM) is a condition that has multi-faceted layers of management due to the initial transient, stress-related, nature of hyperglycemia right after a transplantation, which is not a true state of PTDM. Understanding the differences between transient hyperglycemia allows for effective transitional management between inpatient and outpatient settings. As the effect of post-surgery stress is minimized, blood glucose appears to be normalized. However, understanding the risks that immunosuppression presents to the development of a future hyperglycemic effect minimizes the risk that a patient will be ineffectively managed in the outpatient setting as PTDM is officially diagnosed 3 months post-transplantation at the earliest. An plan to transition from insulin therapy to oral agents with monitoring is essential to preventing loss to follow-up and readmissions for DKA.
Early control of blood glucose leads to better outcomes for the transplant recipient and for graft longevity. After attending the session, the audience will also explore the latest evidence that suggests newer oral agents reduce the risk of graft vasculopathies in addition to the expected renal and cardiovascular complications of a diabetic state. Evidence for diabetic management in patients with a transplanted organ is sparse, and this CE will look to provide clinicians the knowledge to limit the financial and clinical impact of uncontrolled PTDM.
 

Objectives

  • Describe the pathophysiology, risk factors, and complications of PTDM
  • Summarize the different treatment strategies for PTDM
  • Review current literature and trials supporting treatment options for PTDM
  • Outline an evidence-based treatment plan for a patient case by applying current literature

Speaker(s)/Author(s)

Connor McKay, PharmD
PGY1/MS Health-System Pharmacy Administration & Leadership Resident

Activity Number

0046-9999-21-177-L01-P
Date: 06/17/21
Time: 05:00 PM - 06:00 PM

CE Hours

1.00

Fee

$10.00

Location

Online